ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Luminous Global Announces 4th Annual Light Up the Night: "The Enchanted Garden" to Benefit the Luminous Advocacy Project

An evening of candlelight, music, and advocacy at the Mayfair House Hotel & Garden to support early breast cancer detection and awareness worldwide

MIAMI, FLORIDA / ACCESS Newswire / September 11, 2025 / Luminous Global announces the 4th Annual Light Up the Night gala, themed "The Enchanted Garden," an unforgettable evening dedicated to advocacy, awareness, and empowerment. The event will take place on Friday, September 26, 2025, from 6:30 p.m. to 11:30 p.m. at the iconic Mayfair House Hotel & Garden in Coconut Grove, Miami.4th Annual Light Up the Night: “The Enchanted Garden”

4th Annual Light Up the Night: “The Enchanted Garden”
4th Annual Light Up the Night: “The Enchanted Garden” will take place on Friday, September 26, 2025, from 6:30 p.m. to 11:30 p.m. at the iconic Mayfair House Hotel & Garden in Coconut Grove, Miami.

Guests will be welcomed into a magical garden setting, illuminated by candlelight and enhanced by live music, inspiring stories, and meaningful tributes. The evening will honor this year's awardees, advocates, and changemakers whose efforts continue to shape the future of breast health awareness.

Proceeds from the gala will benefit The Luminous Advocacy Project, a nonprofit organization dedicated to promoting early detection of possible breast abnormalities, advancing education, and ensuring equitable medical access for women everywhere. Through its initiatives, the project empowers women and men to take charge of their health and supports the global mission of reducing disparities in breast cancer outcomes.

The event will also spotlight Luminous, the first breast familiarity tool designed to give users a visual reference of their breast health and encourage an awareness-first lifestyle. This innovative technology illuminates soft tissue and blood flow in the breast, helping individuals establish a personal baseline to identify changes or potential anomalies over time. Areas that appear darker or shadowed may indicate irregularities, prompting further medical attention.

"I believe that living an awareness lifestyle is key and that early detection does save lives," says Luminous Global Founder & CEO, Marylin Dans. "If we can catch cancer early, we can save thousands of lives."

Luminous is a non-invasive, CE-labeled Class I medical device in the EU/UK that uses a no-risk visualization technique to enhance breast familiarity. While not intended to replace physician visits or screenings, the tool encourages routine self-exams between regular check-ups, empowering women and men to take an active role in their healthcare.

Currently available in the EU and UK, Luminous Global is expanding to the Middle East and the United States with the mission of bringing hope, empowerment, and reassurance to women across the globe.

Link to purchase tickets HERE.

About Luminous Global
Luminous Global is redefining the landscape of breast health through education, advocacy, and innovation. The company's pioneering technology, Luminous, is the first breast familiarity tool designed to empower individuals to actively monitor their health. By combining innovation with global advocacy, Luminous Global strives to ensure that early detection and breast health awareness are accessible to all. For further information, visit luminousglobaltech.com.

Contact Information
Gabriela Gutiérrez
TARA, Ink. Account Executive
gigi@taraink.com

.

SOURCE: Luminous Global



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.